Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma

Clinical trial NCT05694416 · UNKNOWN

Trial details

NCT number: NCT05694416
Sponsor: Zhongnan Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

MGMT-Unmethylated Glioblastoma

Start date: 2023-02-01
Primary completion: 2024-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.